查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014841

體外受精市場：2026年至2032年全球市場預測（按產品類型、胚胎來源、手術類型、應用和最終用戶分類）

In-Vitro Fertilization Market by Product, Embryo Source, Procedure Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，體外受精市場價值將達到 134 億美元，到 2026 年將成長至 147.8 億美元，到 2032 年將達到 274.9 億美元，複合年成長率為 10.81%。

主要市場統計數據
基準年 2025 134億美元
預計年份：2026年 147.8億美元
預測年份 2032 274.9億美元
複合年成長率 (%) 10.81%

新的趨勢和尚未解決的需求正在推動體外受精領域的創新、普及和以患者為中心的解決方案。

體外受精起源於實驗研究，如今已成為生殖醫學的基石，應對複雜的生物學、倫理和經濟挑戰。受晚育和不孕症上升等人口趨勢的影響，市場對先進的實驗室技術和個人化治療方案的需求日益成長。儘管胚胎培養和冷凍保存技術的進步提高了成功率，但不斷變化的法規結構仍在影響技術的可及性和保險報銷機制。患者的期望也在改變；如今的準父母們希望獲得透明的治療結果指標、微創手術以及能夠即時監測治療進展的數位互動工具。

技術突破與以患者為中心的策略相結合，正在重新定義全球體外受精的成功指標和進入模式。

體外受精領域正經歷一場變革，主要得益於實驗室自動化、數位化監測和精準醫療的突破性進展。互聯平台和雲端資料管理的整合，使得對培養箱的遠端監測以及預測胚胎活力的分析儀錶板成為可能。此外，人工智慧演算法與胚胎學家在胚胎分級方面的專業知識相輔相成，為成功預測模型開闢了新的範式。伴隨這些技術進步，醫療服務提供者也積極採用以患者為中心的策略，提供遠端醫療諮詢、個人化卵巢刺激療法和客製化的基因檢測服務。

計劃於 2025 年實施的關稅調整正在改變美國體外受精服務提供者的供應鏈、成本結構和策略規劃。

2025年，美國對進口培養基試劑盒、一次性醫療設備和專用實驗室設備加徵新關稅，為體外受精服務提供者帶來了巨大挑戰。這些調整擾亂了長期存在的供應鏈，迫使他們與供應商重新談判，並加速了對國內冷凍保存培養基和顯微操作儀器生產設施的投資。隨著進口成本的上升，診所面臨著要么自行承擔額外費用，要么通過調整服務費用將其轉嫁給患者的壓力，這加劇了成本效益和臨床差異化方面的競爭。

對產品線、胚胎來源選擇、治療方法、臨床應用和終端用戶管道進行全面分析，揭示了各種機會。

對產品類型的深入分析表明，培養基（包括冷凍保存培養基、胚胎培養基、卵子處理液和精子處理試劑）因其對實驗室結果的直接影響，持續吸引研發投入。同時，諸如微流體吸頭和一次性移液管等一次性裝置和配件，透過提高操作的無菌性並最大限度地降低交叉污染的風險，正變得越來越重要。儀器設備領域，包括隔振台、冷凍系統、氣體分析儀、先進成像平台、培養箱、體外受精櫃、雷射系統、顯微操作系統、顯微鏡、抽吸泵、精子分析儀、分離裝置和追蹤解決方案，對於追求操作一致性的實驗室而言仍然至關重要。

美洲、歐洲、中東和非洲以及亞太地區不同的區域趨勢和法規環境造就了獨特的成長模式和投資重點。

美洲地區展現出成熟市場的特徵，包括完善的報銷機制、監管協調的努力以及對個人化生育解決方案的重視。特別是美國診所，正透過遠端保健和消費者導向的基因檢測來提升服務差異化，而加拿大醫療機構則受益於公共資金支持模式。相較之下，歐洲、中東和非洲（EMEA）地區則呈現出各國監管法規的複雜局面，從西歐嚴格的胚胎檢測方法到中東地區對生育旅遊中心的日益成長的投資，再到一些非洲國家相關服務的萌芽發展，不一而足。該地區的醫療機構必須在應對複雜的合規環境的同時，充分利用跨境患者流動。

體外受精市場主要企業的策略定位和創新組合突顯了競爭發展和夥伴關係趨勢。

體外受精市場的主要企業正透過產品平臺的策略多元化和服務網路的拓展來實現差異化競爭。跨國生命科學公司正透過先進的冷凍保存解決方案和人工智慧驅動的胚胎選擇平台來擴展其產品組合，而生殖醫學專家則持續投資於顯微操作技術和照護現場診斷檢測。一些領先企業正在收購區域性連鎖實驗室，以直接取得臨床工作流程和檢體量，並增強其端到端服務模式。

為產業領導者提供最佳化營運、促進合作以及掌握體外受精領域新興機會的實用策略。

產業領導者應優先考慮透過與國內培養基和設備供應商建立合作關係來實現供應鏈多元化，從而降低關稅波動帶來的風險。投資於用於胚胎活力評估和檢查室工作流程自動化的人工智慧技術，將顯著提高臨床效率並縮短受孕時間。拓展遠端醫療和遠距監測能力，將滿足患者對便利性的需求，並提高整個治療週期內的患者留存率。

一個穩健的多階段研究框架，整合了與專家的直接訪談、二手資料的檢驗和定量情境分析。

本研究途徑對50多位不孕症專家、胚胎學家、檢查室管理人員和設備製造商進行了深入訪談，以收集關於技術應用和臨床挑戰的第一手觀點。訪談之後，研究人員進行了二次調查，全面查閱了同行評審的學術期刊、監管文件、專利資料庫和已發布的臨床指南，以檢驗和強化定性研究結果。

透過對技術進步、監管影響和市場動態的全面分析，揭示了體外受精在全球範圍內的發展軌跡和未來前景。

對體外受精現狀的全面分析揭示了技術創新、監管變革和患者​​期望之間錯綜複雜的相互作用，這些因素共同塑造著體外受精的未來。先進的培養基和冷凍保存技術正在為實驗室性能樹立新的標準，而人工智慧和數位健康平台正在重新定義我們與患者的互動方式以及支持臨床決策的方式。美國關稅政策的外溢效應正在推動供應鏈重組並促進國內生產，凸顯了韌性和適應性的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 體外受精市場：依產品分類

  • 培養基
    • 冷凍保存介質
    • 胚胎培養基
    • 卵子處理培養基
    • 精子處理培養基
  • 一次性設備和配件
  • 裝置
    • 隔振台
    • 冷凍系統
    • 氣體分析儀
    • 影像系統
    • 培養箱
    • 體外受精櫃
    • 雷射系統
    • 微型機械手臂系統
    • 顯微鏡
    • 卵子抽吸泵
    • 精子分析系統
    • 精子分離裝置
    • 證人制度

第9章：體外受精市場（依胚胎供應來源分類）

  • 新鮮捐贈者
  • 新鮮非捐贈者
  • 冷凍捐贈者
  • 冷凍非捐贈者

第10章：體外受精市場依治療類型分類

  • 輔助孵化
  • 常規體外受精
  • 冷凍胚胎移植（FET）
  • 輸卵管內配子移植（GIFT）
  • 胞漿內單一精子注射（ICSI）
  • 受精卵輸卵管內移植（ZIFT）

第11章 體外受精市場：依應用領域分類

  • 女性不孕症
    • 子宮內膜異位症
    • 排卵障礙
    • 輸卵管因素不孕症
    • 不明原因不孕
  • 男性不孕
    • 精子形態異常
    • 精子數量減少
    • 精子活力下降

第12章 體外受精市場：依最終用戶分類

  • 門診手術中心
  • 不孕症治療診所
  • 醫院

第13章 體外受精市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 體外受精市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 體外受精市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國體外受精市場

第17章 中國試管嬰兒市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Carl Zeiss AG
  • Cook Medical Inc.
  • CooperSurgical Inc.
  • Corning incorporated
  • Esco micro pte. Ltd.
  • Ferring BV
  • FertiPro NV
  • Genea Biomedx Pty Ltd.
  • Hamilton Thorne, Inc.
  • INVO Bioscience, Inc.
  • IVFtech ApS
  • Kitazato Corporation
  • Laboratoire CCD
  • Meiji Techno Co., Ltd.
  • Merck KGaA
  • Nidacon International AB
  • Nikon Corporation
  • Olympus Corporation
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
Product Code: MRR-43127F7279FE

The In-Vitro Fertilization Market was valued at USD 13.40 billion in 2025 and is projected to grow to USD 14.78 billion in 2026, with a CAGR of 10.81%, reaching USD 27.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.40 billion
Estimated Year [2026] USD 14.78 billion
Forecast Year [2032] USD 27.49 billion
CAGR (%) 10.81%

Emerging Trends and Unmet Needs Propel Innovation, Accessibility, and Patient-Centric Solutions Across the In-Vitro Fertilization Landscape

The in-vitro fertilization discipline has emerged from its experimental origins to become a cornerstone of reproductive health, addressing complex biological, ethical, and economic challenges. Driven by shifting demographic trends such as delayed parenthood and rising infertility rates, the market is witnessing heightened demand for advanced laboratory capabilities and personalized treatment protocols. Technological innovations in embryo culture and cryopreservation have expanded success rates, while evolving regulatory frameworks continue to shape accessibility and reimbursement pathways. Patient expectations are also evolving; today's prospective parents seek transparent outcome metrics, minimally invasive procedures, and digital engagement tools that deliver real-time updates on their treatment journey.

Simultaneously, the convergence of data analytics and artificial intelligence is revolutionizing embryo selection and laboratory workflow optimization, reducing time to pregnancy and improving consistency of outcomes. As competition intensifies among clinics, device manufacturers, and service providers, strategic collaboration and vertical integration are gaining traction as means to control quality and manage costs. In this milieu, ethical considerations surrounding genetic testing and embryo manipulation further underscore the need for robust governance and practitioner training. Altogether, these dynamics set the stage for an era of innovation where patient-centric solutions, operational excellence, and scientific rigor will define leadership in the in-vitro fertilization arena.

Technological Breakthroughs Combined with Patient-Centric Strategies Are Redefining Success Metrics and Access Models in In-Vitro Fertilization Globally

The in-vitro fertilization sector is undergoing a transformative shift fueled by breakthroughs in laboratory automation, digital monitoring, and precision medicine. Integration of connectivity platforms and cloud-based data management is enabling remote monitoring of incubators and analytic dashboards that forecast embryo viability. Furthermore, artificial intelligence algorithms are augmenting embryologists' expertise in grading embryos, ushering in a new paradigm of predictive success modeling. Alongside these technological advances, providers are embracing patient-centric strategies that offer telehealth consultations, personalized ovarian stimulation regimens, and tailored genetic profiling services.

In parallel, the industry is witnessing a consolidation wave among clinics and laboratory suppliers, driven by the pursuit of scale efficiencies and broader geographic coverage. Mergers and strategic alliances are creating regional and global networks that facilitate standardized protocols and pooled resources for research and development. Meanwhile, emerging markets in Asia and South America are recalibrating their regulatory and reimbursement policies to encourage domestic investment and medical tourism. As demand diversifies-with growing awareness of male factor infertility and the rise of fertility preservation among cancer survivors-stakeholders are called upon to innovate across both product and service dimensions, ensuring that clinical excellence and equitable access advance hand in hand.

Projected Tariff Adjustments in 2025 Are Reshaping Supply Chains, Cost Structures, and Strategic Planning for U.S. In-Vitro Fertilization Providers

In 2025, newly enacted U.S. tariffs on imported culture media kits, disposable devices, and specialized laboratory equipment introduced significant headwinds for in-vitro fertilization providers. These adjustments disrupted long-standing supply chains, prompted renegotiation of vendor contracts, and catalyzed investment in domestic manufacturing facilities for cryopreservation media and micromanipulation instruments. As import costs rose, clinics faced pressure to absorb incremental expenses or pass them along through adjusted service fees, intensifying competition on cost efficiency and clinical differentiation.

To mitigate these challenges, many providers established strategic partnerships with local suppliers capable of producing laser systems, incubators, and anti-vibration tables at scale. Others accelerated adoption of modular laboratory designs that allow equipment sharing across service lines, optimizing utilization and reducing capital intensity. Moreover, the tariff environment has spurred exploration of alternate sourcing options, including collaborative R&D agreements with regional biotechnology firms. While these shifts initially introduced complexity, they ultimately fostered supply chain resilience, incentivized innovation in product design, and reinforced the strategic imperative for fertility centers to adopt agile procurement and long-term strategic planning.

Comprehensive Analysis of Product Offerings, Embryo Sourcing Options, Procedure Modalities, Clinical Applications, and End-User Channels Reveals Opportunities

A nuanced examination of product categories reveals that culture media-encompassing cryopreservation media, embryo culture formulations, ovum processing solutions, and sperm processing reagents-continues to command R&D investment due to its direct impact on laboratory outcomes. Alongside this, disposable devices and accessories such as microfluidic chips and single-use transfer pipettes are gaining prominence by enhancing procedural sterility and minimizing cross-contamination risks. The equipment segment, featuring anti-vibration tables, cryosystems, gas analyzers, advanced imaging platforms, incubators, IVF cabinets, laser systems, micromanipulation suites, microscopes, aspiration pumps, sperm analyzers, separation devices, and witness tracking solutions, remains critical for laboratories seeking operational consistency.

Insights into embryo sourcing highlight a dynamic balance between fresh donor and non-donor cycles and the growing prevalence of frozen donor and non-donor transfers, driven by patient preference for cycle flexibility and single embryo transfer protocols. Procedure-type analysis underscores the sustained dominance of conventional IVF and intracytoplasmic sperm injection, complemented by rising adoption of frozen embryo transfer, assisted hatching, gamete intrafallopian transfer, and zygote intrafallopian transfer techniques. In terms of clinical application, female infertility segments such as endometriosis, ovulatory disorders, tubal factor infertility, and unexplained infertility represent the majority of treatment volumes, while male infertility categories-including abnormal sperm morphology, low sperm count, and poor motility-constitute an under-addressed opportunity. Ambulatory surgery centers, fertility clinics, and hospitals collectively define the end-user landscape, each bringing distinct procedural workflows, reimbursement frameworks, and patient engagement models.

Distinct Regional Dynamics and Regulatory Environments Drive Unique Growth Patterns and Investment Priorities Across Americas, EMEA, and Asia-Pacific

The Americas region exhibits mature market characteristics, with established reimbursement pathways, regulatory harmonization efforts, and a focus on personalized fertility solutions. U.S. clinics, in particular, are leveraging telehealth and direct-to-consumer genetic testing to differentiate their services, while Canadian providers benefit from supportive public funding models. In contrast, the Europe, Middle East & Africa corridor encompasses a mosaic of national regulations, ranging from stringent embryo testing laws in Western Europe to growing investment in fertility tourism hubs in the Middle East and nascent service development in select African nations. Providers in this region must navigate complex compliance landscapes while capitalizing on cross-border patient flows.

Asia-Pacific stands out as the fastest-growing region, propelled by government initiatives in China and India that expand fertility treatment accessibility and catalyze local manufacturing of laboratory consumables and instruments. Japan and South Korea are enhancing regulatory frameworks to incorporate advanced genetic diagnostics, and Australia and New Zealand maintain high standards for clinical accreditation and laboratory quality. Across these regions, varying demographic profiles, cultural attitudes toward fertility, and reimbursement mechanisms create differentiated growth trajectories, underscoring the necessity for targeted entry strategies and localized value propositions.

Strategic Positioning and Innovation Portfolios of Leading Industry Players Illuminate Competitive Advancements and Partnership Trends in In-Vitro Fertilization

Leading organizations in the in-vitro fertilization market are distinguishing themselves through strategic diversification of their product pipelines and expansion of service networks. Multinational life science firms have augmented their portfolios with advanced cryopreservation solutions and AI-enabled embryo selection platforms, while specialized reproductive health companies continue to invest in micromanipulation technologies and point-of-care diagnostic assays. Several key players have pursued acquisition of regional laboratory chains to secure direct access to clinic workflows and specimen volumes, reinforcing end-to-end service models.

Collaborations between equipment manufacturers and fertility providers have introduced bundled offerings that integrate hardware, consumables, and data analytics in subscription-based frameworks. Concurrently, cross-industry partnerships with genetic testing companies are facilitating seamless integration of preimplantation genetic screens. Emerging players have differentiated through agile product development cycles and localized manufacturing strategies, particularly in Asia-Pacific markets. Taken together, these competitive dynamics illustrate a landscape where technological prowess, strategic alliances, and nimble go-to-market approaches will dictate market leadership and shape the next wave of innovation.

Actionable Strategies for Industry Leaders to Optimize Operations, Foster Collaboration, and Capitalize on Emerging In-Vitro Fertilization Opportunities

Industry leaders should prioritize diversification of their supply chains by forging partnerships with domestic media and equipment suppliers to mitigate exposure to tariff fluctuations. Investing in artificial intelligence for embryo viability assessment and laboratory workflow automation can yield measurable improvements in clinical efficiency and reduce time to pregnancy. Expanding telehealth and remote monitoring capabilities will cater to patient demand for convenience and strengthen retention across treatment cycles.

Providers are encouraged to cultivate collaborative ecosystems with academic research centers and technology startups to accelerate innovation in genetic diagnostics and cryopreservation methodologies. Implementing lean manufacturing principles for consumables and adopting modular laboratory architectures can optimize capital allocation and enhance scalability. To address emerging male infertility demands, organizations should integrate targeted diagnostic services and specialized treatment protocols into their offerings. Finally, proactive monitoring of evolving regulatory requirements across key regions will enable agile compliance and future-proofed market entry strategies.

Robust Multi-Phase Research Framework Integrating Primary Expert Engagement, Secondary Data Validation, and Quantitative Scenario Analysis

The research approach employs a multi-phase framework that began with in-depth interviews conducted with over fifty fertility specialists, embryologists, laboratory directors, and equipment manufacturers to capture first-hand perspectives on technological adoption and clinical challenges. Following these discussions, secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory filings, patent databases, and published clinical guidelines to validate and augment qualitative insights.

Quantitative analysis was performed through scenario modeling to assess the impact of tariff changes and regional regulatory variations on cost structures and adoption rates. Data triangulation techniques reconciled findings across primary and secondary sources, ensuring consistency and rigor. Furthermore, expert panels convened throughout the process provided iterative validation of assumptions, while internal peer review and methodological audits guaranteed transparency and reproducibility. Ethical considerations, data privacy protocols, and quality control measures underpinned each stage to deliver robust and credible market intelligence.

Synthesis of Technological Advances, Regulatory Impacts, and Market Dynamics Illustrates the Evolutionary Path and Future Outlook of Global In-Vitro Fertilization

In synthesizing the landscape of in-vitro fertilization, it becomes evident that technological innovation, regulatory evolution, and patient expectations are intricately interwoven in shaping future trajectories. Advanced culture media and cryopreservation techniques are setting new benchmarks for laboratory performance, while artificial intelligence and digital health platforms are redefining patient engagement and clinical decision support. The ripple effects of U.S. tariff policies have prompted supply chain realignment and encouraged domestic production, underscoring the importance of resilience and adaptability.

Segmentation analysis highlights the criticality of aligning product offerings with emerging procedural preferences and clinical applications, particularly in under-addressed male infertility categories. Regional insights reveal that tailored market entry strategies and local partnerships will be essential to capitalize on diverse growth drivers. Competitive dynamics among leading players demonstrate that integrated service models, strategic alliances, and agile manufacturing approaches will determine market leadership. As stakeholders navigate these converging trends, a steadfast focus on operational excellence, ethical governance, and patient-centric innovation will chart the course for sustained success in the global in-vitro fertilization sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. In-Vitro Fertilization Market, by Product

  • 8.1. Culture Media
    • 8.1.1. Cryopreservation Media
    • 8.1.2. Embryo Culture Media
    • 8.1.3. Ovum Processing Media
    • 8.1.4. Sperm Processing Media
  • 8.2. Disposable Devices & accessories
  • 8.3. Equipment
    • 8.3.1. Anti-vibration Tables
    • 8.3.2. Cryosystems
    • 8.3.3. Gas Analyzers
    • 8.3.4. Imaging Systems
    • 8.3.5. Incubators
    • 8.3.6. IVF Cabinets
    • 8.3.7. Laser Systems
    • 8.3.8. Micromanipulator Systems
    • 8.3.9. Microscopes
    • 8.3.10. Ovum Aspiration Pumps
    • 8.3.11. Sperm Analyzer Systems
    • 8.3.12. Sperm Separation Devices
    • 8.3.13. Witness Systems

9. In-Vitro Fertilization Market, by Embryo Source

  • 9.1. Fresh Donor
  • 9.2. Fresh Non-donor
  • 9.3. Frozen Donor
  • 9.4. Frozen Non-donor

10. In-Vitro Fertilization Market, by Procedure Type

  • 10.1. Assisted Hatching
  • 10.2. Conventional IVF
  • 10.3. Frozen Embryo Transfer (FET)
  • 10.4. Gamete Intrafallopian Transfer (GIFT)
  • 10.5. Intracytoplasmic Sperm Injection (ICSI)
  • 10.6. Zygote Intrafallopian Transfer (ZIFT)

11. In-Vitro Fertilization Market, by Application

  • 11.1. Female Infertility
    • 11.1.1. Endometriosis
    • 11.1.2. Ovulatory Disorders
    • 11.1.3. Tubal Factor Infertility
    • 11.1.4. Unexplained Infertility
  • 11.2. Male Infertility
    • 11.2.1. Abnormal Sperm Morphology
    • 11.2.2. Low Sperm Count
    • 11.2.3. Poor Sperm Motility

12. In-Vitro Fertilization Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Fertility Clinics
  • 12.3. Hospitals

13. In-Vitro Fertilization Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. In-Vitro Fertilization Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. In-Vitro Fertilization Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States In-Vitro Fertilization Market

17. China In-Vitro Fertilization Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Carl Zeiss AG
  • 18.6. Cook Medical Inc.
  • 18.7. CooperSurgical Inc.
  • 18.8. Corning incorporated
  • 18.9. Esco micro pte. Ltd.
  • 18.10. Ferring B.V.
  • 18.11. FertiPro N.V.
  • 18.12. Genea Biomedx Pty Ltd.
  • 18.13. Hamilton Thorne, Inc.
  • 18.14. INVO Bioscience, Inc.
  • 18.15. IVFtech ApS
  • 18.16. Kitazato Corporation
  • 18.17. Laboratoire CCD
  • 18.18. Meiji Techno Co., Ltd.
  • 18.19. Merck KGaA
  • 18.20. Nidacon International AB
  • 18.21. Nikon Corporation
  • 18.22. Olympus Corporation
  • 18.23. Thermo Fisher Scientific Inc.
  • 18.24. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO FERTILIZATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IN-VITRO FERTILIZATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM PROCESSING MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM PROCESSING MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM PROCESSING MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM PROCESSING MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM PROCESSING MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM PROCESSING MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY DISPOSABLE DEVICES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY DISPOSABLE DEVICES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY DISPOSABLE DEVICES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ANTI-VIBRATION TABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ANTI-VIBRATION TABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ANTI-VIBRATION TABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOSYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOSYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAS ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAS ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INCUBATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INCUBATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IVF CABINETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IVF CABINETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IVF CABINETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM SEPARATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM SEPARATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY WITNESS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY WITNESS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY WITNESS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH DONOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH NON-DONOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH NON-DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN DONOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN DONOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN NON-DONOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN NON-DONOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN NON-DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ASSISTED HATCHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ASSISTED HATCHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ASSISTED HATCHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CONVENTIONAL IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CONVENTIONAL IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER (GIFT), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER (GIFT), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER (GIFT), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ENDOMETRIOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ENDOMETRIOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVULATORY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVULATORY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY TUBAL FACTOR INFERTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY TUBAL FACTOR INFERTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY TUBAL FACTOR INFERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY UNEXPLAINED INFERTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY UNEXPLAINED INFERTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY UNEXPLAINED INFERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ABNORMAL SPERM MORPHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ABNORMAL SPERM MORPHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ABNORMAL SPERM MORPHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LOW SPERM COUNT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LOW SPERM COUNT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LOW SPERM COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY POOR SPERM MOTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY POOR SPERM MOTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY POOR SPERM MOTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 231. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 232. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 233. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 238. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 261. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 262. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 263. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 268. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 271. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 272. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 273. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 274. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 277. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 278. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)